# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-24-103737
Filing Date
2024-09-05
Accepted
2024-09-05 07:32:48
Documents
25
Period of Report
2024-09-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | neog-20240905.htm iXBRL | 8-K | 38905
2 | EX-99.1 | neog-ex99_1.htm | EX-99.1 | 15184
3 | GRAPHIC | neog-ex99_1s1.jpg | GRAPHIC | 634760
4 | GRAPHIC | neog-ex99_1s2.jpg | GRAPHIC | 701728
5 | GRAPHIC | neog-ex99_1s3.jpg | GRAPHIC | 363735
6 | GRAPHIC | neog-ex99_1s4.jpg | GRAPHIC | 405082
7 | GRAPHIC | neog-ex99_1s5.jpg | GRAPHIC | 537922
8 | GRAPHIC | neog-ex99_1s6.jpg | GRAPHIC | 338659
9 | GRAPHIC | neog-ex99_1s7.jpg | GRAPHIC | 532969
10 | GRAPHIC | neog-ex99_1s8.jpg | GRAPHIC | 480361
11 | GRAPHIC | neog-ex99_1s9.jpg | GRAPHIC | 409790
12 | GRAPHIC | neog-ex99_1s10.jpg | GRAPHIC | 359372
13 | GRAPHIC | neog-ex99_1s11.jpg | GRAPHIC | 357696
14 | GRAPHIC | neog-ex99_1s12.jpg | GRAPHIC | 191010
15 | GRAPHIC | neog-ex99_1s13.jpg | GRAPHIC | 385010
| Complete submission text file | 0000950170-24-103737.txt |  | 8021197

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
16 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | neog-20240905.xsd | EX-101.SCH | 25022
27 | EXTRACTED XBRL INSTANCE DOCUMENT | neog-20240905_htm.xml | XML | 4730

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 241279957
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)